Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

NCT00488605 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00488605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis
Lead sponsor
University of New Mexico
Phase
Phase 3
Overall status
Withdrawn
Start date
August 1, 2023
Completion date
August 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia